TrialClinical cancer research : an official journal of the American Association for Cancer Research2021

Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial.

Reetta Virtakoivu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.